CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 31 filers reported holding CHAMPIONS ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,000 | -1.0% | 31,238 | 0.0% | 0.00% | – |
| Q2 2023 | $196,000 | +55.6% | 31,238 | 0.0% | 0.00% | – |
| Q1 2023 | $126,000 | -10.6% | 31,238 | 0.0% | 0.00% | – |
| Q4 2022 | $141,000 | -29.1% | 31,238 | +18.0% | 0.00% | -100.0% |
| Q3 2022 | $199,000 | -7.0% | 26,467 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $214,000 | -0.5% | 26,467 | 0.0% | 0.00% | – |
| Q1 2022 | $215,000 | +1.4% | 26,467 | 0.0% | 0.00% | – |
| Q4 2021 | $212,000 | -21.5% | 26,467 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $270,000 | +35.0% | 26,467 | +36.2% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | -9.1% | 19,427 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $220,000 | +22.9% | 19,427 | +17.0% | 0.00% | 0.0% |
| Q4 2020 | $179,000 | +16.2% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $154,000 | -3.1% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $159,000 | +29.3% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | -10.9% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $138,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $7,111,000 | 7.42% |
| NEA Management Company, LLC | 1,562,500 | $5,688,000 | 0.25% |
| SHEPHERD KAPLAN KROCHUK, LLC | 21,564 | $78,000 | 0.05% |
| Perceptive Advisors | 366,973 | $1,335,000 | 0.04% |
| Granite Investment Partners, LLC | 139,698 | $509,000 | 0.03% |
| Sandy Spring Bank | 8,333 | $30,000 | 0.00% |
| Veritas Investment Management (UK) Ltd | 2,083 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,753 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 152,722 | $553,000 | 0.00% |
| MORGAN STANLEY | 3,500 | $13,000 | 0.00% |